Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| PSKYParamount Skydance Corp | $12.25B | — | $29.21B | -1.5% | -$6.19B | $1.63B | $16.2B | Fair valued |
| ELANElanco Animal Health Inc | $12.27B | — | $4.72B | +6.2% | -$232M | $530M | $3.92B | Overvalued |
| SFStifel Financial Corp | $12.32B | 14.6× | $3.77B | +14.5% | $683.78M | $2.19B | $1.46B | Fair valued |
| GLPIGaming & Leisure Properties, Inc. | $12.32B | 12.4× | $1.59B | +4.1% | $825.11M | $319M | $8.32B | Fair valued |
| HBMHudbay Minerals Inc. | $12.34B | 16.8× | $2.21B | +9.4% | $564.3M | $568.9M | $1.06B | Overvalued |
| PACPacific Airport Group | $12.39B | 19.4× | MX$33.61B | +1.2% | MX$8.88B | MX$13.47B | MX$48.03B | Fair valued |
| HUBSHubspot Inc | $12.41B | 88.1× | $3.13B | +19.2% | $45.91M | $958.31M | $236.91M | Fair valued |
| TXRHTexas Roadhouse, Inc. | $12.49B | 30.5× | $5.88B | +9.4% | $414.34M | $202.43M | $1.09B | Overvalued |
| HALOHalozyme Therapeutics, Inc. | $12.5B | 32.9× | $1.4B | +37.6% | $316.89M | $163.14M | $2.18B | Undervalued |
| MANHManhattan Associates Inc | $12.53B | 61.5× | $1.08B | +3.7% | $219.95M | $186.11M | $53.88M | Overvalued |
| TMETencent Music Entertainment Group | $12.53B | 9.9× | CN¥28.4B | +2.3% | CN¥7.11B | CN¥13.16B | CN¥325M | Undervalued |
| CCKCrown Holdings, Inc. | $12.54B | 16.6× | $12.37B | +4.8% | $738M | $656M | $6.27B | Fair valued |
| FNFFidelity National Financial, Inc. | $12.54B | 16.3× | $2.1B | +9.1% | $602M | $3.58B | $4.74B | Undervalued |
| CSGPCostar Group, Inc. | $12.54B | 170.4× | $3.25B | +18.7% | $7M | $1.27B | $1.16B | Overvalued |
| AURAurora Innovation, Inc. | $12.55B | — | $3M | — | -$816M | $136M | $82M | Overvalued |
| BF-BBrown Forman Corp | $12.56B | 17.6× | $3.93B | -1.2% | $715M | $301M | $2.44B | Fair valued |
| IESCIES Holdings, Inc. | $12.58B | 28.0× | $3.37B | +16.9% | $305.98M | $77.28M | $76.94M | Overvalued |
| MDGLMadrigal Pharmaceuticals, Inc. | $12.6B | — | $958.4M | +432.1% | -$288.28M | $292.73M | $347.75M | Fair valued |
| DKSDick's Sporting Goods, Inc. | $12.6B | 15.1× | $17.22B | +28.1% | $849.24M | $913.74M | $6.06B | Fair valued |
| COKECoca-Cola Consolidated, Inc. | $12.65B | 26.0× | $7.23B | +4.8% | $570.58M | $171.69M | $2.62B | Fair valued |